154 related articles for article (PubMed ID: 20462081)
1. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome.
Pantasri T; Vutyavanich T; Sreshthaputra O; Srisupundit K; Piromlertamorn W
J Med Assoc Thai; 2010 Apr; 93(4):406-12. PubMed ID: 20462081
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.
Weerakiet S; Bunnag P; Phakdeekitcharoen B; Wansumrith S; Chanprasertyothin S; Jultanmas R; Thakkinstian A
Gynecol Endocrinol; 2007 Mar; 23(3):153-60. PubMed ID: 17454169
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
4. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
Liang P; Xi L; Shi J; Li W; Zhao S; Deng Y; Wang R; Sun Y; Gu B; Yuan L; Zhang Y; Gu W; Wang W; Hong J
Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
8. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
[TBL] [Abstract][Full Text] [Related]
9. Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists.
Dhesi AS; Murtough KL; Lim JK; Schulkin J; McGovern PG; Power ML; Morelli SS
Am J Obstet Gynecol; 2016 Nov; 215(5):579.e1-579.e5. PubMed ID: 27457114
[TBL] [Abstract][Full Text] [Related]
10. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil.
Maffazioli GDN; Lopes CP; Heinrich-Oliveira V; Lobo RA; Hayashida SAY; Soares JM; Maciel GAR; Baracat EC
Int J Gynaecol Obstet; 2020 Dec; 151(3):383-391. PubMed ID: 32931592
[TBL] [Abstract][Full Text] [Related]
12. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
13. Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
Vaggopoulos V; Trakakis E; Chrelias C; Panagopoulos P; Basios G; Makridima S; Sioulas VD; Simeonides G; Labos G; Boutati E; Kassanos D
J Endocrinol Invest; 2013; 36(7):478-84. PubMed ID: 23211631
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital.
Wongwananuruk T; Indhavivadhana S; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Angsuwathana S; Dangrat C
J Med Assoc Thai; 2010 Apr; 93(4):399-405. PubMed ID: 20462080
[TBL] [Abstract][Full Text] [Related]
16. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profile in women with polycystic ovary syndrome across adult life.
Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
[TBL] [Abstract][Full Text] [Related]
18. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
[TBL] [Abstract][Full Text] [Related]
19. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
